Archives: Speakers

Dan Keeley

Dan Keeley has been working in data engineering for over 15 years. He was named one of the UKs top 50 data influencers in 2016. He is now Chief Engineer at hubb (Named challenger of the year) – an exciting Scottish insurtech working on transforming the broking market.

Henry Lin

Henry is a Vice President of Data Sciences at Medidata. His team’s mission is to build scalable data science and engineering software services that are integrated into Medidata platform to accelerate the generation of actionable insights across the clinical development lifecycle. Previously, he has led and worked on data science teams across different functions at Janssen Pharmaceuticals, Johnson & Johnson Medical Device Companies and Roche Pharmaceuticals. Henry earned his B.S. in Electrical Engineering & Computer Science from UC Berkeley and Ph.D. in Biological & Medical Informatics from UCSF.

Meghan Harrington

Meghan serves as the VP, Clinical Trial Financial Management at Medidata driving roadmap and strategy across our Grants Manager and Site Payments products. Meghan started her career as a Masters level psychologist working within a medical care team treating patients with ALS and traumatic brain injury. It was through this privileged relationship with patients facing devastating diagnoses that Meghan witnessed first hand the life-saving and life-enhancing effects of medical and therapeutic intervention thus piquing her interest in the drug development process. Meghan joined a CNS-focused start up in RTP and has spent the last 15+ years working in the life science technology industry. The last decade of this time has been solely focused on the investigator grant administration domain driving strategy and leading teams implementing payment technology in both BPO and enablement models.

Brendan Krause

Brendan has over 20 years of policy, strategy and business development experience in health
care. He began his career at the National Governors Association in Washington, DC, working
on health reform between the US Federal Government and states. Following NGA, Brendan
attended the London School of Economics as a Fulbright Scholar, where he studied the impact
of the Blair Government’s choice and competition reforms in the NHS and earned an MSc in
International Health Policy and Economics. He then spent 12 years working for Optum in the
UK in a number of UK and global strategy roles, with a focus on use of data to improve
population health. Recently, Brendan joined Uber as Head of International for Health, where he
is building a global strategy to remove transportation and logistics as a barrier to care.